Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer

Samankaltaisia teoksia

• Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
  Tekijä: Bum Sik Tae, et al.
  Julkaistu: (2017-01-01)
• Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
  Tekijä: Kim, Byung Soo, et al.
  Julkaistu: (2018)
• Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
  Tekijä: Yuk, Hyeong Dong, et al.
  Julkaistu: (2018)
• Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
  Tekijä: Yuk, Hyeong Dong, et al.
  Julkaistu: (2019)
• Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
  Tekijä: Kang, Minyong, et al.
  Julkaistu: (2016)